Atrial Fibrillation Market: By Treatment Type (Non-pharmacological, Pharmacological, Others), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Others) and Geography.

Purchase Option

$ 4400
$ 6600
$ 8900

Atrial fibrillation market size was valued at USD 1,945.6 million in 2022 and is expanded to grow at a significant CAGR of 7.2% from 2023-2029. Atrial fibrillation is the most common problem with the heartbeat's rate or rhythm. Atrial fibrillation is caused by disordered signals that cause the two top chambers of the heart (the atria) to squeeze very quickly and out of sync. The increased prevalence of heart attacks and high blood pressure among people is driving the atrial fibrillation industry. Furthermore, the market is also boosted by the prevalence of obesity, diabetes, and metabolic syndrome. The market is predicted to develop due to the growing patient pool and the geriatric population suffering from lifestyle diseases like atherosclerosis and heart failure. The key players are manufacturing advanced catheter ablation for the treatment of atrial fibrillation and reducing the risk of stroke in patients, which has paved the way for lucrative opportunities in the industry. A favorable regulatory scenario would also propel growth in this market. Due to an increase in the adoption of cardiac monitoring systems during the treatment of atrial fibrillation, the surgical segment generated the most revenue in 2020. By end-user, the hospital segment registered the highest revenue in 2021, owing to the increased adoption of laser and radiofrequency methods for catheter ablation. An increase in the number of patients with arrhythmia or an irregular heartbeat problem has resulted in a growth in demand for cardiac monitors.

Atrial Fibrillation Market Key Developments: 
  • In Feb 2022, Boston Scientific Corporation announced the close of its acquisition of Baylis Medical Company Inc., a company that offers advanced transseptal access solutions as well as guidewires, sheaths, and dilators used to support catheter-based left-heart procedures.
  • In Jan 2022, Medtronic plc, a global leader in healthcare technology, announced that it has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company. Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) such as atrial fibrillation (AF).

Global Atrial Fibrillation Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Atrial Fibrillation Market Dynamics

Because of the rising patient pool and the geriatric population suffering from lifestyle diseases such as atherosclerosis and heart failure, the market is expected to rise. Furthermore, due to the rising prevalence of obesity, the number of persons suffering from atrial fibrillation is rising. As a result, it's thought that increasing obesity rates are adding to the market's expansion. Scarcity of experienced professionals and adverse preference for pharmacological treatments over atrial fibrillation devices are the main factors hampering the global atrial fibrillation market.

Key Features of the Reports

  • The atrial fibrillation market report provides granular level information about the market size, regional market share, historic market (2018 to 2022), and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Atrial Fibrillation Market Segmentation

By Treatment Type
  • Non-pharmacological
  • Pharmacological
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The atrial fibrillation market is projected to expand at a CAGR of 7.2% during the forecast period

The major key players operating in the market are AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Inc., Johnson and Johnson Ltd., Abbott Laboratories

North American is the fastest-growing region for atrial fibrillation market

1. Executive Summary
2. Global Atrial Fibrillation Market Introduction 
2.1.Global Atrial Fibrillation Market  - Taxonomy
2.2.Global Atrial Fibrillation Market  - Definitions
2.2.1.Treatment Type
2.2.2.End User
2.2.3.Region
3. Global Atrial Fibrillation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Atrial Fibrillation Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Atrial Fibrillation Market  By Treatment Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Non-pharmacological
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Pharmacological
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Atrial Fibrillation Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Ambulatory Surgical Centers
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cardiac Catheterization Laboratories
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Atrial Fibrillation Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Atrial Fibrillation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Treatment Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Non-pharmacological
8.1.2.Pharmacological
8.1.3.Others
8.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Ambulatory Surgical Centers
8.2.3.Cardiac Catheterization Laboratories
8.2.4.Others
8.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Atrial Fibrillation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Non-pharmacological
9.1.2.Pharmacological
9.1.3.Others
9.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Ambulatory Surgical Centers
9.2.3.Cardiac Catheterization Laboratories
9.2.4.Others
9.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
9.3.7.
10. Asia Pacific (APAC) Atrial Fibrillation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Non-pharmacological
10.1.2.Pharmacological
10.1.3.Others
10.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Ambulatory Surgical Centers
10.2.3.Cardiac Catheterization Laboratories
10.2.4.Others
10.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Atrial Fibrillation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Non-pharmacological
11.1.2.Pharmacological
11.1.3.Others
11.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Ambulatory Surgical Centers
11.2.3.Cardiac Catheterization Laboratories
11.2.4.Others
11.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Atrial Fibrillation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Treatment Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Non-pharmacological
12.1.2.Pharmacological
12.1.3.Others
12.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Ambulatory Surgical Centers
12.2.3.Cardiac Catheterization Laboratories
12.2.4.Others
12.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1. AtriCure, Inc.
13.2.2. Biosense Webster, Inc.
13.2.3. Boehringer Ingelheim GmbH
13.2.4. Boston Scientific Corporation
13.2.5. Bristol-Myers Squibb Corporation
13.2.6. CardioFocus, Inc.
13.2.7. Endoscopic Technologies, Inc.
13.2.8. Sanofi Aventis, Inc.
13.2.9. Johnson and Johnson Ltd.
13.2.10. Abbott Laboratories
14. Research Methodology 
15. Appendix and Abbreviations 
  • AtriCure, Inc.
  • Biosense Webster, Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc.
  • Sanofi Aventis, Inc.
  • Johnson and Johnson Ltd.
  • Abbott Laboratories

Adjacent Markets